Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis-Reference-Cited by-同舟云学术

Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis

Published:2017-03-06 Issue:9 Volume:45 Page:1193-1200
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Guarino M.¹,Morisco F.¹,Valvano M. R.²,Ippolito A. M.²^ORCID,Librandi M.³,Andriulli N.⁴,Greco M.⁵,Amoruso A.⁶,Iacobellis A.²,Niro G.²,Caporaso N.¹,Andriulli A.²

Affiliation:

1. Gastroenterology Unit; Department of Clinical Medicine and Surgery; Federico II University; Naples Italy

2. Division of Gastroenterology; Casa Sollievo Sofferenza Hospital; IRCCS; San Giovanni Rotondo Italy

3. Pharmacia Librandi; Cirò Marina Italy

4. Pharmacia Tor Millina; Rome Italy

5. Division of Internal Medicine and Clinical Immunology; San Martino Hospital; IRCCS; Genova Italy

6. Division of Emergency Medicine; San Carlo Hospital; Potenza Italy

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14017/fullpdf

Reference31 articles.

1. Competing risks and prognostic stages of cirrhosis: a 25-year inception color study of 494 patients;D'Amico;Aliment Pharmacol Ther,2014

2. Prevalence and challenges of liver diseases in patients with chronic hepatitis C infection;Jacobson;Clin Gastroenterol Hepatol,2010

3. Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies;Petta;Gastroenterology,2016

4. Outcome of sustained virological responders with histologically advanced chronic hepatitis C;Morgan;Hepatology,2010

5. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Van der Meer;JAMA,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches;World Journal of Gastroenterology;2022-06-14

2. Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study;Cancers;2021-07-29

3. Uptake of interferon‐free DAA therapy among HCV‐infected decompensated cirrhosis patients and evidence for decreased mortality;Journal of Viral Hepatitis;2021-07-08

4. lnc‐HOTAIR predicts hepatocellular carcinoma in chronic hepatitis C genotype 4 following direct‐acting antivirals therapy;Molecular Carcinogenesis;2020-10-19

5. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C;Experimental and Clinical Transplantation;2020-10